Saab AB SAAB B ORD SHS/ SE0021921269 /
24/05/2024 18:36:55 | Chg. - | Volume | Bid14:42:32 | Ask14:42:32 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
249.05SEK | - | 15,127 Turnover: 2.8 mill. |
226.10Bid Size: 2,000 | 235.50Ask Size: 2,000 | 124.33 bill.SEK | 0.69% | 36.62 |
GlobeNewswire
03/06
uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational G...
Newsfile Corp
11/04
Tor Holding and ELIE SAAB Announce Partnership for Dual Real Estate Debut in Turkey
GlobeNewswire
04/04
Schneider Electric announces global winners of second edition of its Sustainability Impact Awards
GlobeNewswire
03/04
SK hynix announces semiconductor advanced packaging investment in Purdue Research Park
GlobeNewswire
19/12/2023
uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of ...
GlobeNewswire
29/11/2023
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-191 Gene Therapy for...
GlobeNewswire
13/11/2023
Bombardier Defense Delivers Seventh Global Aircraft for Saab’s GlobalEye Airborne Surveillance Solut...
GlobeNewswire
03/11/2023
Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial o...